ITB-MED
PrivateLast Round
VC Round
Apr 4, 2018
Company Overview
ITB-MED is a biotechnology company that develops immunomodulatory biologics, including its lead candidate Siplizumab (TCD601), for the treatment of transplantation, autoimmunity, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ITB-MED Comparables
Compare ITB-MED with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quell Therapeutics | 78% | |
| TolerogenixX GmbH | 76% | |
| Bristol Myers Squibb | 69% |
ITB-MED Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 4, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2018
$67M round led by Pablo Legorreta
ITB-MED Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ITB-MED's valuation, stock price, and market status.
Is ITB-MED a public or private company?
ITB-MED is a private company.
What is the current stock price of ITB-MED?
ITB-MED is a private company with no public stock price. No recent secondary market data is available.
How much is ITB-MED worth (valuation)?
Valuation information for ITB-MED is not publicly available.
Can I buy ITB-MED stock?
ITB-MED shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ITB-MED's last funding round?
ITB-MED's most recent funding round was VC Round on April 4, 2018.
Who are the main investors in ITB-MED?
Investor information for ITB-MED is not publicly disclosed.
Will ITB-MED IPO soon?
No public IPO plans have been announced for ITB-MED.
How can I track ITB-MED secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ITB-MED's secondary market activity and sign up for updates.